Ngā hua rapu - Chih‐Cheng Lai
- E whakaatu ana i te 1 - 20 hua o te 59
- Haere ki te Whārangi Whai Ake
-
1
The COVID-19 pandemic and tuberculosis in Taiwan mā Chih‐Cheng Lai, Weng-Liang Yu
I whakaputaina 2020Carta -
2
COVID-19 associated with pulmonary aspergillosis: A literature review mā Chih‐Cheng Lai, Weng-Liang Yu
I whakaputaina 2020Revisão -
3
-
4
-
5
-
6
COVID-19 associated mucormycosis – An emerging threat mā Chien‐Ming Chao, Chih‐Cheng Lai, Wen‐Liang Yu
I whakaputaina 2022Revisão -
7
-
8
How Taiwan has responded to COVID-19 and how COVID-19 has affected Taiwan, 2020–2022 mā Chih‐Cheng Lai, Ping‐Ing Lee, Po‐Ren Hsueh
I whakaputaina 2023Revisão -
9
-
10
-
11
-
12
-
13
-
14
In vitro diagnostics of coronavirus disease 2019: Technologies and application mā Chih-Cheng Lai, Cheng‐Yi Wang, Wen‐Chien Ko, Po‐Ren Hsueh
I whakaputaina 2020Revisão -
15
Increased antimicrobial resistance during the COVID-19 pandemic mā Chih‐Cheng Lai, Shey‐Ying Chen, Wen‐Chien Ko, Po‐Ren Hsueh
I whakaputaina 2021Revisão -
16
-
17
<p>The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a syste... mā Chih‐Cheng Lai, Cheng–Hsin Chen, Charlotte Lin, Cheng‐Yi Wang, Yahui Wang
I whakaputaina 2019Revisão -
18
-
19
-
20
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Disease
Biology
Microbiology
Coronavirus disease 2019 (COVID-19)
Infectious disease (medical specialty)
Antibiotics
Intensive care medicine
Virology
Pathology
Meta-analysis
Outbreak
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Pandemic
Physics
Pneumonia
Randomized controlled trial
Bacteria
Confidence interval
Genetics
Biochemistry
Coronavirus
Environmental health
Antibiotic resistance
Bacteremia
Cohort
Immunology
Incidence (geometry)
Intensive care unit